Finerenone Added to RAS/SGLT2 Blockade for CKD in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3-/- Mice.
Finerenone添加至Alport症候群的RAS/SGLT2阻斷治療中。與Col4a3-/-小鼠進行的隨機對照試驗結果。
J Am Soc Nephrol 2023-10-18
A small molecule chaperone rescues keratin-8 mediated trafficking of misfolded podocin to correct genetic Nephrotic Syndrome.
一種小分子伴護劑拯救角蛋白-8介導的錯誤折疊的podocin運輸,以修正遺傳性腎症候群。
Kidney Int 2024-03-27
Urinary Protein-Biomarkers Reliably Indicate Very Early Kidney Damage in Children With Alport Syndrome Independently of Albuminuria and Inflammation.
Alport 綜合症兒童尿蛋白生物標記可可靠地指示非白蛋白尿和發炎之外的極早期腎損傷。
Kidney Int Rep 2024-01-31
X-linked Alport syndrome presenting in mother and son with the same unique histopathological features.
X連鎖Alport綜合症在母親和兒子中呈現相同獨特的組織病理特徵。
J Nephrol 2024-04-26
Preventing MMP23-mediated cleavage of podocyte RARRES1: a novel strategy to halt chronic kidney disease progression?
阻止MMP23介導的足細胞RARRES1裂解:一種阻止慢性腎臟疾病進展的新策略?
Kidney Int 2024-06-21